Colonization and infection with multidrug-resistant organisms
Conditions
Interventions
Group 1: Prospectively, all patients with documented C. auris and ventricular assist devices (VADs) will be followed with regard to the occurrence of predefined endpoints. In addition to clinical endp
Sponsors
Institut für Hygiene und Umweltmedizin- Charité Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Colonization with C. auris and cluster affiliation with a specific sequence type
Exclusion criteria
Exclusion criteria: No detection of the cluster-defining sequence type No consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endpoints are death or sustained clearance of C. auris. Follow-up visits every 3 months include assessment of colonization status as well as the patient’s clinical condition. Assessment is performed using microbiological swab samples every 3–6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of phenotypic resistance development to antiseptic agents Transplantation and infection Risk factors for persistence of colonization Quality of life | — |
Countries
Germany
Contacts
Public ContactFriederike Maechler
Institutfür Hygiene und Umweltmedizin- Charité Berlin
Outcome results
None listed